A new recombinant pituitary adenylate cyclase-activating peptide-derived peptide efficiently promotes glucose uptake and glucose-dependent insulin secretion.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Acta Biochimica et Biophysica Sinica

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/abbs/gms078PMID 23052710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms for increased insulin-stimulated Akt phosphorylation and glucose uptake in fast- and slow-twitch skeletal muscles of calorie-restricted rats.

  2011cited by this paper
• The effects of prenatal stress on expression of CaMK-II and L-Ca2+ channel in offspring hippocampus.

  2011cited by this paper
• Evaluation of chylomicron effect on ASP production in 3T3-L1 adipocytes.

  2011cited by this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Glucose Production via the Hepatic Sympathetic Innervation in Rats

  2010cited by this paper
• Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes.

  2010cited by this paper
• Expression, identification and biological effects of a novel VPAC2-specific agonist with high stability and bioactivity.

  2010cited by this paper
• Cloning and Expression of the New Gene Recombinant RMBAY Against Type-2 Diabetes and Its Production Optimization

  2009cited by this paper
• Physiological and Molecular Determinants of Insulin Action in the Baboon

  2008cited by this paper
• Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats.

  2006cited by this paper
• 1-Benzyl-1,2,3,4-tetrahydroisoquinoline-6,7-diols as novel affinity and photoaffinity probes for beta-adrenoceptor subtypes.

  2006cited by this paper
• Treatment of Renal Failure Associated with Multiple Myeloma and Other Diseases by PACAP‐38

  2006cited by this paper
• VIP–PACAP System in Immunity

  2006cited by this paper
• Neuroprotection by endogenous and exogenous PACAP following stroke.

  2006cited by this paper
• Insulin signaling diverges into Akt-dependent and -independent signals to regulate the recruitment/docking and the fusion of GLUT4 vesicles to the plasma membrane.

  2006cited by this paper
• Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic β‐cell: implications for the treatment of type 2 diabetes

  2005cited by this paper
• Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects.

  2005cited by this paper
• Pituitary adenylate cyclase-activating polypeptide prevents cell death in the spinal cord with traumatic injury

  2005cited by this paper
• Overexpression of PACAP in transgenic mouse pancreatic beta-cells enhances insulin secretion and ameliorates streptozotocin-induced diabetes.

  2003cited by this paper
• Generation of Highly Selective VPAC2 Receptor Agonists by High Throughput Mutagenesis of Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Peptide*

  2003cited by this paper
• A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes.

  2002cited by this paper
• Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor

  2002cited by this paper
• Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation.

  2001cited by this paper
• Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis

  2001cited by this paper
• Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.

  2000cited by this paper
• Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction.

  2000cited by this paper
• The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily.

  2000cited by this paper
• THE ORIGIN AND FUNCTION OF THE PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP)/GLUCAGON SUPERFAMILY

  2000cited by this paper
• Protein Kinase B/Akt Participates in GLUT4 Translocation by Insulin in L6 Myoblasts

  1999cited by this paper
• SIGNAL TRANSDUCTION: Lipid-Regulated Kinases: Some Common Themes at Last

  1998cited by this paper
• Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems.

  1998cited by this paper
• Development of high affinity selective VIP1 receptor agonists.

  1997cited by this paper
• Expression of a Constitutively Active Akt Ser/Thr Kinase in 3T3-L1 Adipocytes Stimulates Glucose Uptake and Glucose Transporter 4 Translocation*

  1996cited by this paper
• Overexpression of Catalytic Subunit p110α of Phosphatidylinositol 3-Kinase Increases Glucose Transport Activity with Translocation of Glucose Transporters in 3T3-L1 Adipocytes*

  1996cited by this paper
• Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part I: In vitro and in vivo bronchodilator studies.

  1994cited by this paper
• Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38).

  1990cited by this paper
• Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells.

  1989cited by this paper
• Calculation of protein extinction coefficients from amino acid sequence data.

  1989cited by this paper

• Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes

  2022influential citation
• A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects

  2017cites this paper
• A novel recombinant slow-release TNF α-derived peptide effectively inhibits tumor growth and angiogensis

  2015cites this paper
• Effects of fucoidan on insulin stimulation and pancreatic protection via the cAMP signaling pathway in vivo and in vitro.

  2015cites this paper
• A New Recombinant PACAP-Derived Peptide Efficiently Promotes Corneal Wound Repairing and Lacrimal Secretion.

  2015cites this paper